Chiamaka Ukachukwu
Associate Director, Clinical Biomarkers @Eli Lilly and Company
Signup · Get unlimited contacts
WORK HISTORY
Associate Director, Clinical Biomarkers @Eli Lilly and Company
Indianapolis, IN, US
Leading strategic biomarker planning for early phase neuroscience and pain assets. • Collaborate on cross-functional teams and leverage stakeholder management to ensure on-time delivery of clinical biomarker assays for Ph1 programs. Anticipate and proactively plan for future biomarker needs to eliminate program delays.• Ensure fit-for-purpose use of biomarkers by bridging scientific strategy and operational excellence. Support seamless transition between early phase and late phase biomarker planning through detailed documentation of biomarker plans and partnership with late phase Therapeutic Area leads. • Led process improvement for cross-functional biomarker advisory reviews by introducing a structured preparation and stakeholder alignment approach, setting a precedent adopted across subsequent programs.• Facilitate consultations with subject matter experts (SMEs) and key opinion leaders (KOLs) to align analytical validation and regulatory strategy with biomarker context of use. Present recommendations to executive leadership on prioritization of biomarker assays to accelerate and simplify clinical trial execution.• Peer-coaching three early-career employees across the Clinical Laboratory Sciences (CLS) and the Talent Development Academy (TDA) organizations.
EDUCATION
Georgia Institute of Technology
Bachelor of Science (B.S.), Biochemistry, French Minor
University of Michigan College of Literature, Science, and the Arts
Master’s Degree - M.S., Molecular, Cellular, and Developmental Biology
Université catholique de Louvain
Certificat de Recherche en sciences médicales - MD 3 CE, Molecular Biology
University of Michigan Medical School
Doctor of Philosophy - Ph.D., Pharmacology
Franklin High School
High School Diploma
ABOUT CHIAMAKA UKACHUKWU
Clinical development leader supporting biomarker strategy for Ph1/Ph2 neurodegeneration and pain therapeutics. Quick to take initiative, embrace new challenges, and deliver results in fast-paced, evolving environments. Expert in relationship building and integrating quickly into cross-functional teams. • Skilled communicator and experienced public speaker, able to present complex topics to general audiences. • Interested in global opportunities using science to drive positive change across borders; French speaker, working toward professional proficiency• Expertise in Pharmacology, Electrophysiology (hERG, ion channels), Molecular and Structural Biology (infectious diseases, structure-activity-relationship/SAR), with over 10 years\' R&D experience in academia.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.